Baclofen: Effective Muscle Spasticity Relief and Control
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.18 (0%) | 🛒 Add to cart |
| 90 | $0.76 | $78.27 $68.23 (13%) | 🛒 Add to cart |
| 120 | $0.71 | $104.36 $85.29 (18%) | 🛒 Add to cart |
| 180 | $0.66 | $156.54 $118.40 (24%) | 🛒 Add to cart |
| 270 | $0.62 | $234.80 $168.58 (28%) | 🛒 Add to cart |
| 360 | $0.61
Best per pill | $313.07 $218.75 (30%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.38 | $101.35 (0%) | 🛒 Add to cart |
| 60 | $2.53 | $202.69 $151.52 (25%) | 🛒 Add to cart |
| 90 | $2.23 | $304.04 $200.69 (34%) | 🛒 Add to cart |
| 120 | $2.09 | $405.39 $250.86 (38%) | 🛒 Add to cart |
| 180 | $1.95 | $608.08 $350.20 (42%) | 🛒 Add to cart |
| 270 | $1.85
Best per pill | $912.12 $499.71 (45%) | 🛒 Add to cart |
Baclofen is a centrally-acting skeletal muscle relaxant, classified as a gamma-aminobutyric acid (GABA) derivative, specifically designed to manage and alleviate symptoms associated with muscle spasticity. It functions as a GABA-B receptor agonist, primarily exerting its effects at the spinal cord level to inhibit monosynaptic and polysynaptic reflex transmission. This pharmacological action results in reduced muscle tone and frequency of spasms, offering significant therapeutic benefits for patients with neurological conditions. Its efficacy is well-established in clinical practice, making it a cornerstone in the management of spastic hypertonia.
Features
- Pharmacological Class: Gamma-aminobutyric acid (GABA) analogue; GABA-B receptor agonist.
- Mechanism of Action: Acts primarily at the spinal cord level to hyperpolarize afferent terminals, thereby inhibiting the release of excitatory neurotransmitters and suppressing monosynaptic and polysynaptic reflex activity.
- Formulations: Available in oral tablets (10mg and 20mg strengths) and intrathecal solution for direct delivery via an implanted pump.
- Bioavailability: Oral administration demonstrates approximately 70-85% absorption from the gastrointestinal tract.
- Half-life: The elimination half-life ranges from 2.5 to 4 hours in patients with normal renal function.
- Metabolism and Excretion: Minimally metabolized in the liver; approximately 70-85% is excreted unchanged by the kidneys via glomerular filtration.
Benefits
- Provides significant reduction in the frequency and severity of painful muscle spasms and clonus.
- Effectively decreases muscle tone and rigidity, improving passive and active range of motion.
- Enhances functional capacity and performance of daily activities for individuals with chronic spasticity.
- Contributes to improved ease of nursing care and physiotherapy for bedbound or severely affected patients.
- The intrathecal delivery system allows for direct spinal cord targeting, maximizing efficacy while minimizing systemic side effects for treatment-resistant cases.
- Offers a well-tolerated profile for long-term management of chronic neurological conditions when dosed appropriately.
Common use
Baclofen is primarily indicated for the management of muscle spasticity resulting from multiple sclerosis, spinal cord injuries, and other spinal cord diseases (e.g., transverse myelitis, syringomyelia). It is also utilized off-label for the treatment of certain types of intractable hiccups, trigeminal neuralgia, and muscle spasms associated with cerebral palsy. Its use is targeted at symptomatic relief, improving mobility, reducing discomfort, and facilitating rehabilitation efforts. It is not a cure for the underlying neurological disorder but is a critical component of a comprehensive spasticity management plan.
Dosage and direction
Dosage must be individualized for each patient based on response and tolerability. The goal is to achieve the lowest effective dose.
Oral Administration (Adults):
- Initial Dose: 5 mg orally three times daily.
- Titration: May increase by 5 mg per dose every 3 days until the desired effect is achieved.
- Therapeutic Range: The optimum therapeutic dosage typically lies between 40-80 mg daily, administered in divided doses (3-4 times per day).
- Maximum Dose: Doses exceeding 80 mg daily are not recommended. Experience is limited.
Discontinuation: Abrupt withdrawal must be avoided due to the risk of serious adverse reactions, including hallucinations and seizures. Dosage should be tapered gradually over a period of 1 to 2 weeks, unless serious side effects necessitate immediate cessation.
Intrathecal Administration:
- Reserved for severe spasticity unresponsive to oral therapy or poorly tolerated.
- Requires implantation of a programmable pump and catheter by a specialist.
- Dosage is highly individualized and titrated via screening trial and subsequent pump refills and programming. Initial screening dose is typically 50 mcg.
Important: Take oral tablets with food or milk to minimize gastrointestinal upset. Follow the prescribing physician’s instructions precisely; do not adjust the dose without consultation.
Precautions
- Renal Impairment: Baclofen is primarily renally excreted. Dosage reduction is necessary in patients with impaired renal function to prevent accumulation and toxicity.
- Seizure Disorders: Use with caution in patients with a history of epilepsy or seizures, as baclofen may lower the seizure threshold.
- Stroke Patients: Caution is advised in patients who have had a recent stroke, as clinical experience is limited and efficacy may be reduced.
- Psychiatric Disorders: Use with caution in patients with psychiatric disorders, schizophrenia, or confusional states, as baclofen can exacerbate these conditions.
- Autonomic Dysreflexia: Patients with spinal cord injuries at T6 or above should be monitored for autonomic dysreflexia, especially during dose titration or withdrawal.
- Pregnancy and Lactation: Use during pregnancy only if the potential benefit justifies the potential risk to the fetus (Pregnancy Category C). Baclofen is excreted in human milk; caution is advised if administering to a nursing woman.
- Operate Machinery/Dizziness: Baclofen may cause drowsiness, dizziness, or blurred vision. Patients should be cautioned about operating machinery, driving, or engaging in activities requiring mental alertness until they know how the drug affects them.
Contraindications
Baclofen is contraindicated in patients with:
- A known hypersensitivity to baclofen or any component of the formulation.
- Active peptic ulcer disease (relative contraindication due to potential for GI effects).
Possible side effect
Side effects are often dose-related and may diminish with time or dose reduction.
Common (≥1%):
- Drowsiness, sedation, dizziness
- Nausea, constipation
- Muscle weakness, fatigue
- Headache, insomnia
- Hypotension (low blood pressure)
Less Common/Serious:
- Confusion, hallucinations, agitation, depression
- Slurred speech, visual disturbances, nystagmus
- Respiratory depression (more common with intrathecal use)
- Seizures (particularly upon abrupt withdrawal)
- Rash, pruritus (itching)
- Urinary frequency, enuresis
- Elevated liver enzymes, jaundice
Drug interaction
Baclofen has the potential to interact with other CNS depressants, enhancing their effects.
- Alcohol and Other CNS Depressants: Concomitant use with opioids, benzodiazepines (e.g., alprazolam, diazepam), sedatives, hypnotics, or tricyclic antidepressants can lead to profound sedation, respiratory depression, coma, and death. Avoid combination or monitor closely.
- Antihypertensives: May potentiate the effects of antihypertensive drugs, increasing the risk of hypotension.
- MAO Inhibitors: Concurrent use may increase the CNS-depressant and hypotensive effects of baclofen.
- Levodopa: Cases of mental confusion, agitation, and hallucinations have been reported with concomitant use.
Missed dose
- If a dose is missed, it should be taken as soon as remembered.
- However, if it is almost time for the next scheduled dose, skip the missed dose and resume the usual dosing schedule.
- Do not double the dose to make up for a missed one.
Overdose
Signs and Symptoms: Manifestations of overdose are primarily sudden and severe exacerbation of known side effects. Key symptoms include:
- Profound drowsiness, lightheadedness, dizziness, somnolence progressing to coma.
- Respiratory depression, hypoventilation, apnea.
- Seizures.
- Slurred speech, blurred vision.
- Hypotension, bradycardia (slow heart rate), hypothermia.
- Vomiting, diarrhea, increased salivation.
Management:
- Immediate medical attention is critical. Maintain an open airway and institute assisted ventilation if necessary.
- ECG and cardiac monitoring is advised.
- Management is primarily supportive. There is no specific antidote.
- Gastric lavage or activated charcoal may be considered if ingestion was recent and the patient’s airway is protected.
- Seizures may be treated with benzodiazepines (with caution due to additive CNS depression).
- Hemodialysis may be beneficial in removing baclofen, especially in patients with renal impairment.
Storage
- Store at room temperature (20°C to 25°C or 68°F to 77°F), away from light, moisture, and heat.
- Do not store in the bathroom.
- Keep all medications out of the reach of children and pets.
- Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As a neurologist with over 20 years of experience treating MS patients, baclofen remains a first-line, reliable option for managing spasticity. Its dose-dependent efficacy allows for fine-tuning to a patient’s specific needs.” — Dr. E. Vance, MD, Neurology.
- “The transition to intrathecal baclofen was life-changing for my patient with severe spinal cord injury. The targeted delivery provided spasticity control that oral medications could not achieve, with markedly reduced systemic side effects.” — Dr. A. Silva, Physical Medicine & Rehabilitation.
- “While effective, the sedative properties can be a significant limiting factor, especially in the elderly population. Slow titration and patient education are paramount for successful therapy.” — Clinical Pharmacist Review.
- “From a patient perspective, it gave me back a significant degree of control over my muscle stiffness. The initial drowsiness faded after a few weeks, and the benefits have been well worth it.” — Patient with MS, long-term user.